# Franklin Genomic Advancements ETF

Franklin Genomic Advancements ETF is a ETF series of Franklin Templeton ETF Trust (series S000067393). Net assets $21.4M as of 2026-03-31.

## Profile

- Series ID: S000067393
- Registrant: Franklin Templeton ETF Trust
- LEI: 549300JUSHGE4MAFSG36
- Net assets: $21.4M
- Total assets: $21.5M
- As of: 2026-03-31
- Type: ETF

## Advisers

- [Franklin Advisers, Inc. (Advisor)](https://search.stillhousedata.com/firm/104517)

## Top holdings (122 reported)

_Showing 15 of 122 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Guardant Health Inc](https://search.stillhousedata.com/security/40131M109) | GH | $1.5M | 676.96% |
| [Guardant Health Inc](https://search.stillhousedata.com/security/40131M109) | — | $1.5M | 676.96% |
| [NATERA INC](https://search.stillhousedata.com/security/632307104) | NTRA | $1.4M | 664.95% |
| [NATERA INC](https://search.stillhousedata.com/security/632307104) | — | $1.4M | 664.95% |
| [Krystal Biotech Inc](https://search.stillhousedata.com/security/501147102) | — | $1.1M | 532.13% |
| [Krystal Biotech Inc](https://search.stillhousedata.com/security/501147102) | KRYS | $1.1M | 532.13% |
| [United Therapeutics Corporation](https://search.stillhousedata.com/security/91307C102) | — | $996K | 464.50% |
| [United Therapeutics Corporation](https://search.stillhousedata.com/security/91307C102) | UTHR | $996K | 464.50% |
| [Insmed Inc](https://search.stillhousedata.com/security/457669307) | INSM | $970K | 452.28% |
| [Insmed Inc](https://search.stillhousedata.com/security/457669307) | — | $970K | 452.28% |
| [Bridgebio Pharma Inc](https://search.stillhousedata.com/security/10806X102) | BBIO | $905K | 422.15% |
| [Bridgebio Pharma Inc](https://search.stillhousedata.com/security/10806X102) | — | $905K | 422.15% |
| [Ligand Pharmaceuticals Incorporated](https://search.stillhousedata.com/security/53220K504) | LGND | $757K | 353.18% |
| [Ligand Pharmaceuticals Incorporated](https://search.stillhousedata.com/security/53220K504) | — | $757K | 353.18% |
| AstraZeneca PLC | — | $729K | 339.78% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $21.4M |
| 2025-12-31 | $21.8M |
| 2025-09-30 | $17.0M |
| 2025-06-30 | $11.1M |
| 2025-03-31 | $10.8M |
| 2024-12-31 | $13.0M |
| 2024-09-30 | $9.7M |
| 2024-06-30 | $9.5M |

## More

- [Registrant: Franklin Templeton ETF Trust](https://search.stillhousedata.com/registrant/1655589)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000067393.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.